SPHK1 and breast cancer: Hyperexpression of SphK1 was seen in breast cancer tissues and correlated with high levels of S1P. Inhibiting SphK1 decreased metastatic potential in breast cancer cell lines. Increased S1P levels was identified to activate Notch signalling through the S1PR3